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Effect of Helicobacter pylori eradication on endo-
scopic and histological changes of gastric adenoma
2
Backgrounds and Aims Helicobacter pylori 
H.pylori  infection causes gastric adenoma and gastric 
cancer. The ef cacy of H.pylori eradication for existing 
gastric neoplasia is unknown. This study investigated 
the efficacy of H.pylori eradication for existing gastric 
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adenoma.
Material and Methods We followed up 27 patients 
with gastric adenoma underwent H.pylori eradication 
from April 1997 to December 1997. We evaluated the 
endoscopic and histological changes of gastric adenoma 
more than 3 years. We analyzed the relationship 
between endoscopic and histological changes and the 
following clinicopathological factors using univariate 
analysis : follow-up periods, age, gender, serum 
pepsinogen level, lesion size, lesion location, and 
phenotypic expression.
Result The total mean follow-up periods were 91.9 
months. 12 lesions 44.4%  disappeared in endoscopic 
findings, and 7 lesions 25.9%  disappeared in both 
endoscopic and histological ndings. The mean period 
of showing endoscopic disappearances were 21.8 months 
after H.pylori eradication. 6 22.2%  lesions were 
diagnosed intra-mucosal cancer in the follow-up periods, 
resul ting in  performed endoscopic t reatments .
Univariate analysis revealed that gender p=0.009 , 
lesion size p=0.025 , and serum pepsinogen 2 level 
before H.pylori eradication p=0.041  were significant 
a ssoc i a ted  wi th  endoscopic  and  h i s to log ica l 
disappearance of lesions.
Conclusions H.pylori eradication might effect to 
some of gastric adenoma disappearing. Therefore, 
H.pylori eradication can be first therapy for gastric 
adenoma.
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EUS guided placement of plastic vs bi anged met-
al stents for therapy of walled-off necrosis : a ret-
rospective single-centre series
:
Objective Recently, a novel fully covered and 
bi anged metal stent BFMS  dedicated to the drainage 
of walled-off necrosis WON  has been developed.
The aim of this study is to retrospectively evaluate the 
safety, efficacy and cost performance of drainage of 
WON using a novel BFMS compared with a traditional 
plastic stent.
Methods Seventy patients with symptomatic WON 
were treated under EUS guidance. Initial drainage 
using the single gateway technique with placement of 
one or more plastic stents PS  or a BFMS. When 
ineffective, direct endoscopic necrosectomy DEN  was 
performed. 
Results There were no statistically significant 
differences in technical, clinical and adverse event rates 
between PS and BFMS though the size of WON in 
BFMS group was significantly larger than that in PS 
group 77.1 mm vs 105.6 mm, p = 0.003 . The mean 
procedure time of 1st EUS-guided drainage and mean 
procedure time of re-intervention was significantly 
shorter in the BFMS group than the PS group 28.8 7.1 
vs. 42.6 14.2, respectively ; p <0.001 and 34.9 8.5 
vs. 41.8 7.6, respectively ; p <0.001 . There was no 
statistically significant difference in total cost between 
PS and BFMS in treatment of WON $5352 vs. $6274, p 
= 0.25 . 
Conclusions PS and BFMS are equally safe and 
effective for the treatment of WON. In particular, BFMS 
placement seems to be preferable at initial EUS-guided 
drainage and additional reintervention like DEN to 
reduce the procedure time. Prospective randomized 
controlled trial is warranted.
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